Robust and sensitive, the PyroMAT® Monocyte Activation Test system is a non-animal based method for the detection of endotoxin and non-endotoxin pyrogens. Download our studies
List view / Grid view
Filter the results
This whitepaper from NSF explains how to conduct an efficient and effective review and approval of incident reports.
This whitepaper from Beckman Coulter explores GMP cleanroom routine environmental monitoring and data integrity.
Q Biomed entered into a Named Patient Programme distribution agreement for Strontium89, a non-opioid metastatic bone cancer pain drug.
This article explores what pharmaceutical companies could be doing to promote injectable biosimilar approval and consumer uptake.
The cervical dysplasia drug-device product, APL-1702 (Cevira®), offers an alternative to surgery and has been approved to start a clinical trial in China and several other countries.
Scientists unveil their model, which other researchers can use to test the injectability of their drug delivering microparticle designs in silico.
The sustainable device, consisting of food industry by-products, had excellent biocompatibility both in vitro and in vivo.
The FDA has given approval to Phesgo for injection under the skin to treat HER2-positive breast cancer, meaning it can be administered at home by a healthcare professional.
How implantable systems and microparticle depot injections are meeting the needs of long-acting drug delivery
Implantable systems and microparticle depots are used in many areas of drug delivery to release medicines at a controlled rate within the body. The use of these long-acting dosage forms eliminates the need for frequent administrations via traditional routes of administration, which ensures patient compliance and results in improved outcomes.…
The articles in this in-depth focus outline the advantages of repurposing existing drugs for new indications and reveal why implantable systems and microparticle depots as drug delivery systems can aid patient compliance.